Table 5 |
|||||
|
Meta-analyses of association between p53 mutations, p16 and HPV |
|||||
|
Before outlier exclusion |
After outlier exclusion |
||||
|
Outcome |
Marker |
No. of Studies |
Adjusted OR (95% CI) |
No. of Studies |
Adjusted OR (95% CI) |
|
|
|||||
|
HPV positive |
p53 (mutated) |
4 |
0.21(0.04-0.38) |
4 |
0.21(0.04-0.38) |
|
P = 0.015 |
|||||
|
HPV positive |
p16 |
2 |
5.02(1.08-8.97) |
1 |
3.00(0.90-9.70) |
|
IHC |
p = 0.181 |
||||
|
|
|||||
|
Dayyani et al. Head & Neck Oncology 2010 2:15 doi:10.1186/1758-3284-2-15 |
|||||
